Adrenal Crisis: A Discourse Across Borders and the Importance of Universal Design | Julia Anthony

Adrenal Crisis:
A Discourse Across Borders and
the Importance of Universal Design

Julia Anthony
Founder & CEO, SOLUtion Medical

Adrenal Crisis: A Discourse Across Borders and the Importance of Universal Design

Session info:

Julia Anthony leads a discussion with Dr. Mitchell Geffner and individuals and families living with adrenal disease from around the globe.

The discussion will be joined by:

- Mitchell Geffner, MD
- Jenna Whaley Coura
- Ify Aforka
- Berryl Sawyers Hook
- Shaffali Deepak Khanna
- Rachel Pegler Doodledays
- Sam Iliades

Julia is the Founder & CEO of SOLUtion Medical — a life science company developing more patient friendly drug delivery systems for reconstitutable drugs. Together with its affiliates, SOLUtion has and continues to advance social medical device innovation especially within the adrenal insufficiency sphere.

A graduate of West Chester University where she studied Kinesiology and Nutrition, Julia earned her M.S. in Industrial Design from Jefferson University, concentrating in medical device creation and user interaction. A scholar athlete who diligently practices self-improvement, Julia thoroughly enjoys learning. Julia actively advocates and educates on behalf of the rare disease community and serves on the Young Adult Advisory Board for the CARES Foundation. As a young woman living with a rare medical condition, Julia brings her experience and rigor as a designer, entrepreneur, healthcare professional and patient to the life sciences.

SOLUtion Medical is developing a drug delivery device for patient-injected medications that require mixing directly prior to injection. The self-injection market is growing. Worldwide healthcare is trending towards more at-home treatments and pharma companies are seeking ways to deliver high-volume drugs for self-treatment in a timely manner. The self-injected drug delivery market is approximately $38B and has been growing at a CAGR of 19%. A large percentage of these drugs currently require lyophilization, and the FDA predicts 50% of all injectable drugs will require reconstitution in the near future.

SOLUtion’s beachhead market is a rescue autoinjector for individuals at risk of an adrenal crisis, a situation similar to anaphylaxis where a patient’s body experiences physical and mental debilitation requiring immediate injection of hydrocortisone sodium succinate (HSS). The current and only adrenal crisis rescue injection on the market comes in the form of the Act-o-Vial, a system requiring 14 user steps, including cumbersome drug mixing, prior to injection.

SOLUtion Medical is solving this problem with our patent-pending combination drug delivery device which requires only one step to mix the needed life-saving medication and prepare the device for injection. Our device automatically removes air and can be activated in any orientation. With our simpler, faster, and safer solution we aim to improve user experience, increase adherence, improve outcomes, decrease healthcare burden, and, most importantly, save lives.

In addition to the $320m adrenal crisis rescue injection market, numerous drugs currently exist that must be mixed directly prior to injection, including many antipshychotic drugs, in vitro fertilization drugs, monoclonal antibodies, cancer treatments, and multiple in-pipeline drugs. These are all multibillion dollar markets with specific and defined spaces where a device such as SOLUtion’s can gain traction and provide significant benefits to patients.

Posted on

Peloton responds to concerns over Apple GymKit integration

Third-party hardware integration can be a tricky thing. Peloton this week raised some eyebrows by dropping Apple GymKit compatibility for its Bike Bootcamp program. Users were, naturally, quick to react. The situation left some wondering whether the move was a direct response to Apple’s recent entry into the home exercise market with Fitness+.
A Peloton spokesperson offered the following statement to TechCrunch, “Apple GymKit is designed to work with equipment-based cardio workouts. However, Peloton recently implemented GymKit with Bike Bootcamp, a multi-disciplinary class type that combines strength and cardio, which the feature does not support. Members can still use …

Read More

Posted on

How Jamaica failed to handle its JamCOVID scandal

As governments scrambled to lock down their populations after the COVID-19 pandemic was declared last March, some countries had plans underway to reopen. By June, Jamaica became one of the first countries to open its borders.
Tourism represents about one-fifth of Jamaica’s economy. In 2019 alone, four million travelers visited Jamaica, bringing thousands of jobs to its three million residents. But as COVID-19 stretched into the summer, Jamaica’s economy was in free fall, and tourism was its only way back — even if that meant at the expense of public health.
The Jamaican government contracted with Amber Group, a technology …

Read More

Posted on

Make Time for “Me Time”

We’re all busy. Whether it’s responsibilities at home or at work, many of us focus so much on doing it all that we forget to focus on ourselves. But ensuring your own health and happiness is critical. How do you carve out time for yourself, your health, and your needs when you’re always on?
First, define what you need. We all need the basics of sleep, physical movement, and sufficient food, so ask yourself what you need and what you want. Next, determine what you can do within the time you have. Then, set the time. Scheduling …

Read More

Posted on

Over Half of German Citizens Ready to Be Vaccinated With Sputnik V, Poll Shows

Source: Sputnik V Official website
More than a half of German citizens – 57 percent – have expressed readiness to be inoculated with Russia’s Sputnik V vaccine against the coronavirus if it is approved for use in the European Union and Germany, a poll conducted by the Forsa institute for the RTL media group shows.
According to the pollster, the share of those ready to be vaccinated with Sputnik V in Germany stood at 45 percent in early February, Sputnik News reports.

The poll also indicates that 69 percent of Germans want to be vaccinated against COVID-19 but 44 percent do not want to be …

Read More

Precision: The Future of Preventative Health and Wellbeing | Ali Mostashari

The Future of Preventative Health and Wellbeing

Ali Mostashari
Founder & CEO, LifeNome

Precision health is an emerging area of preventative healthcare that leverages the power of artificial intelligence, big data, and systems biology/omics to develop hyper-personalized risk and needs assessments, recommendations, and products based on an individual's unique biology, physiology, and lifestyle. In this talk, I will provide an overview of precision health, the state of the science, its applications within nutrition, fitness, beauty, insurance, and healthcare industries, and the challenges we need to overcome to make it mainstream.

Ali Mostashari, Ph.D., is a co-founder of LifeNome (, a Precision Health AI company headquartered in New York City. Concurrently he serves as a Member of the Global Futures Council and the Global Innovator Community of the World Economic Forum.

Prior to LifeNome, Ali was an Associate Professor and Program Director at the School of Systems and Enterprises at Stevens Institute of Technology, where he directed the institute's Smart Cities initiative and systems thinking research. From 2004-2008 he served as a LEAD Program Manager and Strategic Resource Manager respectively at the United Nations Development Programme (UNDP) in New York City overseeing a development portfolio of over $1.2 billion.

We help businesses offer curated health and well-being choices for their customers

LifeNome is an Award-winning Precision Health AI company headquartered in New York City. LifeNome leverages biological, physiological, and behavioral data to hyper-personalize needs assessments and health and wellness interventions in the preventative health, nutrition, fitness, insurance and personal care/beauty industries.

LifeNome was founded in 2016 by three PhDs with the singular goal of improving the health and well-being outcomes for every individual on the planet. At our very core, our co-founders believe that science & technology are the greatest tools available to accomplish that mission.

By using cutting-edge science & AI they have helped some of the world’s largest companies offer their customers the most effective products and services personalized for them based on their unique needs. Our genes are unique, isn’t it time the products and services we use are too.

Posted on

OnePlus unveils its smartwatch, and Wear OS is nowhere to be seen

Well before the rumors, we knew this day was coming. After several generations of smartwatches and a handful of headphones, the smartwatch was the next logical step for OnePlus.
At today’s big launch event, the company made its first major wearable official, sporting the decidedly pared-down name, OnePlus Watch. As the title implies, the smartwatch is not a particularly flashy one. It has a minimalist design and, at $159, a price to match.
What’s perhaps most interesting here is the operating system. The Watch will be running the equally straightforwardly named OnePlus Watch OS. Google’s Wear OS was …

Read More

Posted on

Ro raises $500M to grow its remote and in-home primary care platform

Healthcare tech startup Ro has raised $500 million to help fuel continued growth of its hybrid telehealth/in-home primary care platform, which also includes a growing pharmacy business as the company pursues a strategy of vertical integration to optimize delivery and reduce costs for clients. The company’s latest raise is a Series D round, and means it has now raised over $876 million since its 2017 founding.
That may seem like a lot of money, but as Ro co-founder and CEO Zachariah Reitano told me in an interview, it’s actually “peanuts” when it comes to the healthcare industry – which is part …

Read More

Posted on

Deep science: AI is in the air, water, soil and steel

Research papers come out far too rapidly for anyone to read them all, especially in the field of machine learning, which now affects (and produces papers in) practically every industry and company. This column aims to collect some of the most relevant recent discoveries and papers — particularly in but not limited to artificial intelligence — and explain why they matter.
This week brings a few unusual applications of or developments in machine learning, as well as a particularly unusual rejection of the method for pandemic-related analysis.
One hardly expects to find machine learning in the domain of government regulation, if only …

Read More

Posted on

Europe’s rush for a COVID-19 ‘digital pass’ stirs concerns

More details have emerged today about the European Commission’s legislative proposal for a pan-EU ‘digital green pass’ to show verified COVID-19 status. The plan is controversial from a human rights and civil liberties perspective, given the clear risk of discrimination. But privacy and security experts are also raising concerns about the technology architecture that will underpin the system — which has yet to detailed in full.
“The proposal does not yet meet the requirements of data protection and protection against discrimination,” said German Pirate MEP Patrick Breyer in a statement today. “It does not ensure that the digital variant of …

Read More